.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Novartis
Boehringer Ingelheim
Dow
Baxter
Daiichi Sankyo
US Department of Justice
Mallinckrodt
McKesson
US Army

Generated: June 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 080693

« Back to Dashboard
NDA 080693 describes HYDROCORTISONE, which is a drug marketed by Teva, Vintage Pharms, Fougera Pharms Inc, Naska, Taro, Pharmaderm, Alpharma Us Pharms, Elkins Sinn, Perrigo New York, Syosset, Usl Pharma, PII, Inwood Labs, Ivax Pharms, Pharmafair, Roxane, Nexgen Pharma Inc, Sandoz, Parke Davis, Whiteworth Town Plsn, Impax Labs Inc, Purepac Pharm, Altana, Fougera Pharms, Everylife, Watson Labs, Ingram Pharm, G And W Labs, Panray, Vintage, Hikma Intl Pharms, Ferrante, Stiefel, Lannett, Ambix, Teva Pharms, Topiderm, Rising Pharms Inc, Impax Labs, Actavis Mid Atlantic, Mericon, Paddock Llc, Barr, Cenci, Fera Pharms, Akorn, Bel Mar, Ferndale Labs, X Gen Pharms, Wockhardt, Bausch And Lomb, Glenmark Generics, Taro Pharm Inds, Cmp Pharma Inc, Abraxis Pharm, Baxter Hlthcare, Intl Medication, and G And W Labs Inc, and is included in one hundred and twenty NDAs. It is available from thirty-six suppliers. Additional details are available on the HYDROCORTISONE profile page.

The generic ingredient in HYDROCORTISONE is hydrocortisone valerate. There are sixty drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the hydrocortisone valerate profile page.

Summary for NDA: 080693

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details

Pharmacology for NDA: 080693

Suppliers and Packaging for NDA: 080693

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
HYDROCORTISONE
hydrocortisone
CREAM;TOPICAL 080693 ANDA E. FOUGERA & CO. A division of Fougera Pharmaceuticals Inc. 0168-0015 0168-0015-16 453.6 g in 1 JAR (0168-0015-16)
HYDROCORTISONE
hydrocortisone
CREAM;TOPICAL 080693 ANDA E. FOUGERA & CO. A division of Fougera Pharmaceuticals Inc. 0168-0015 0168-0015-31 1 TUBE in 1 CARTON (0168-0015-31) > 28.35 g in 1 TUBE

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength1%
Approval Date:Approved Prior to Jan 1, 1982TE:ATRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Chubb
Teva
QuintilesIMS
Mallinckrodt
Merck
Cantor Fitzgerald
Deloitte
US Army
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot